The iCCA is considered the second most commonly diagnosed primary hepatic malignancy after hepatocellular carcinoma (HCC), presenting several genetic alterations, such as FGFR and IDH1/2 fusion, as well as ARID1A and BRAF mutations [3]. Here, BRAF is linked to hepatocellular carcinoma.